OTC · Medical - Specialties

Spectral Medical Inc (EDTXF) Stock

$0.97 -3.20% OTC: EDTXF Healthcare

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

Valuation

MetricValue
Price$0.97
Market Cap$284.16M
P/E Ratio-9.89
P/B Ratio-5.59
P/S Ratio143.47
EPS (TTM)$-0.16
52-Week High$1.31
52-Week Low$0.58
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE61.00%
ROA-830.76%
ROCE18.69%
Gross Margin-79.25%
Operating Margin-412.28%
Net Margin-2400.00%
Debt/Equity-0.31
Current Ratio0.06

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.0M$2.0M$2.0M$2.0M$2.0M
Operating Profit$-9.0M$-9.0M$-15.0M$-12.0M$-12.0M
Net Profit$-9.0M$-11.0M$-16.0M$-15.0M$-48.0M
EPS$-0.03$-0.04$-0.06$-0.05$-0.16
Op Margin-419.1%-566.3%-957.8%-524.8%-478.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$12.0M$12.0M$5.0M$5.0M$6.0M
Total Liabilities$7.0M$15.0M$22.0M$33.0M$76.0M
Cash$9.0M$8.0M$3.0M$3.0M$4.0M
Borrowings$1.0M$7.0M$9.0M$15.0M$21.0M

Latest News

Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX GlobeNewswire · Jun 25, 2026 Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders GlobeNewswire · Jun 9, 2026 Spectral Medical Provides Updated 12-Month Tigris Trial Mortality Data MT Newswires · Jun 4, 2026 Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial GlobeNewswire · Jun 4, 2026 Spectral Medical Submits PMX Premarket Approval Application to FDA MT Newswires · May 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-9.0M$-10.0M$-11.0M$-9.0M$-10.0M
Investing Cash Flow$-1.0M$0$0$0$0
Financing Cash Flow$2.0M$2.0M$2.0M$-1.0M$0
Net Cash Flow$3.0M$0$-5.0M$0$1.0M
Free Cash Flow$-9.0M$-10.0M$-11.0M$-9.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.10
EV / EBITDA-11.83
FCF Yield-2.81%
Quick Ratio0.05
Interest Coverage-2.00
Return 1Y63.24%
Return 3Y322.71%
Return 5Y216.34%

Ownership

Insiders Held17.20%
Institutions Held12.44%
Institutions Float Held15.02%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Spectral Medical Inc

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Spectral Medical Inc is headquartered in CA.

Spectral Medical Inc (EDTXF) stock trades at $0.97 with a market capitalization of $284.16M. The stock is valued at a price-to-earnings (P/E) ratio of -9.89, price-to-book of -5.59, price-to-sales of 143.47. Over the past 52 weeks the stock has ranged between $0.58 and $1.31, and currently trades 26.0% below its 52-week high.

On profitability, Spectral Medical Inc generates a return on equity (ROE) of 61.00% — well above the market average, a sign of a high-quality business, return on capital employed of 18.69%, an operating margin of -412.28%, a net profit margin of -2400.00%.

Official website: spectraldx.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides